Skip to content

Abstract 10716: The Proteogenomic Landscape of Dilated Cardiomyopathy: Assessing the Interplay of Comorbidities and Pathogenic Variants

Nov 2026 · Circulation · 0 citations

Abstract

Background: Heart failure (HF) arises through distinct etiologies, including ischemic heart disease (IHD) and dilated cardiomyopathy (DCM). We previously generated large-scale cardiac proteomics datasets for IHD, but no comparable analysis has assessed how comorbidities, medications, and pathogenic gene variants shape the cardiac proteome in DCM. Research Question: We hypothesized that these factors exert distinct and interacting effects on the DCM cardiac proteome, defining molecularly distinguishable patient subgroups. Methods: In the largest cardiac proteomics analysis to date, left ventricular samples from patients with IHD (n=65), DCM (n=114), and non-failing controls (n=19) were analyzed by quantitative multiplexed proteomics. Genomic data were obtained by whole-exome sequencing. Findings were further explored using spatial transcriptomics and a mouse model with a point mutation preventing degradation of the extracellular matrix (ECM) proteoglycan versican (VcanE441A). Results: In both DCM and IHD, reduced myofilament-related proteins were accompanied by a marked increase in ventricular ANF. Four DCM patient clusters were identified, defined by comorbidities (hypertension, atrial fibrillation), clinical parameters (sex, body mass index, hematocrit, left ventricular ejection fraction), titin-truncating variants, and circulating ANF levels. DCM patients carrying titin-truncating variants (20%) were enriched in fibrotic clusters (FC=3.6, p<0.001) and associated with downregulation of thick filament constituents. The proteomic signature of lamin-A variants was strongly modulated by comorbidities, requiring consideration of gene-comorbidity interactions for meaningful patient stratification. Among all proteins identified, ventricular ANF levels showed the highest inter-patient variability in DCM and best correlated with versican accumulation (ρ=0.50, p<0.001), independent of collagen content. Spatial transcriptomics confirmed versican expression by fibroblasts adjacent to strained cardiomyocytes (ANF+) in both DCM and IHD. Ventricular ANF expression increased >2-fold in VcanE441A mice (p<0.001), consistent with a versican-rich ECM driving fetal gene re-expression. Conclusion: Our study discerns the contributions of genetic variants, comorbidities, and ECM remodeling to the HF cardiac proteome. The novel link between versican accumulation and ANF induction implicates the ECM in coordinating the cardiomyocyte stress response and fetal gene re-expression in HF.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.